Developing a modified Pulsincap system - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Developing a modified Pulsincap system


Pharmaceutical Technology Europe
Volume 21, Issue 11

Conclusion

Pulsatile drug release during a 24h period, consistent with the requirements for chronopharmaceutical drug delivery, was achieved from insoluble gelatin capsules, in which microencapsulated DS was sealed by a hydrogel plug (guar gum, hydroxypropylmethylcellulose, sodium alginate, sodium carboxymethylcellulose). This modified Pulsincap dosage form could be beneficial to the chronotherapy of RA as it has demonstrated programmable, time and pHdependent, sitespecific drug release, and offers an effective controlledrelease alternative to traditional dosage forms that have been met with poor patient compliance.

Dr Gayatri C.Patel is Assistant Professor at the Department of Pharmaceutics Maliba Pharmacy College Gopal Vidyanagar, Bardoli-Mahuva Road, Surat-394350, Gujarat (India). Tel. +91 2625 255144,255882 Fax +91 2625 255882

Dr Madhabhai M. Patel is Principal and Head of Department of Pharmaceutics and Pharmaceutical Technology at Kalol Institute of Pharmacy (India).

References

1. W.J. Elliott, Postgrad. Med., 110(2), 119–129 (2001).

2. C.B. Subal, Pharmabiz, August 2005.

3. A.J. Swannell, Br. J. Clin. Pract., 38, 16–19 (1983).

4. R. Kinget et al., J. Drug Target., 6(2), 129–149 (1998).

5. S. Sarasija and A. Hota, Indian J. Pharm. Sci., 62, 1–8 (2000).

6. C. Boissier, H. Decousus and B. Perpoint, Annual Review of Chronopharmacology, 7(12), 289–292 (1990).

7. M. Sripathy, M.S. Srinath and K.L.K. Paranjothy, Eastern Pharmacist, 42(498), 97–98 (1999).

8. C.M. Adeyene and P.K. Li, "Diclofenac sodium," in K. Florey, Ed, Analytical profiles of drug substances, Volume 19 (Academic Press, New York, NY, USA, 1990) pp 123–144.

9. M. Alfred, J. Swarbrick and A. Cammarata, Physical Pharmacy, 4th Edition (B. I. Warerly Pvt.Ltd, New Delhi, India, 1999) p 355.

10. L. Lachman, A. Lieberman and J.L. Kinig, The Theory and Practice of Industrial Pharmacy, 4th Edition (Varghese Publishing House, Bombay, India, 1998) pp 67–68.

11. USP 23–NF 18 (USP Convention Inc., Rockville, MD, USA), p 940.

12. H.H. Willard et al., Instrumental Methods of Analysis, 6th Edition (CBS Publishers and Distributors, Delhi, India, 1986) pp 177–216.

13. X. Chen, S.Z. Jun and M.O. Yun, Drug Dev. Ind. Pharm., 31(2), 127–134 (2005).

14. C. Gang et al., World J. Gestroenterol., 10(12), 1769–1774 (2004)

15. R. Morta, L. Jose and J. Vila. J. Contr. Rel., 55(1), 67–77 (1998).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology Europe,
Click here